These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3119551)

  • 1. A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.
    Pérez JL; Riera L; Valls F; Berrocal CI; Berrocal L
    J Antimicrob Chemother; 1987 Sep; 20(3):357-62. PubMed ID: 3119551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterococcus faecalis: in vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against high-level-gentamicin-resistant isolates.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1993; 39(4):248-53. PubMed ID: 8325126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
    Fuursted K
    Chemotherapy; 1988; 34(3):229-34. PubMed ID: 3138078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
    Schick DG; Canawati HN; Montgomerie JZ
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):233-9. PubMed ID: 9458980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp.
    Tripodi MF; Rambaldi A; Utili R; Rosario P; Attanasio V; Locatelli A; Adinolfi LE; Andreana A; Florio A; Ruggiero G
    New Microbiol; 1995 Jul; 18(3):319-23. PubMed ID: 7553370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.
    Chen HY; Williams JD
    Eur J Clin Microbiol; 1984 Oct; 3(5):436-8. PubMed ID: 6238822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of periodontal Enterococcus faecalis.
    Rams TE; Feik D; Mortensen JE; Degener JE; van Winkelhoff AJ
    J Periodontol; 2013 Jul; 84(7):1026-33. PubMed ID: 23106507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.
    Itokazu GS; Nathan C; Hariharan R; Kostman JR; Kabins SA; Weinstein RA
    Chemotherapy; 1996; 42(4):235-9. PubMed ID: 8804789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.
    Liao CH; Huang YT; Tsai HY; Hsueh PR
    Int J Antimicrob Agents; 2014 Jul; 44(1):85-6. PubMed ID: 24888868
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
    Kim MJ; Weiser M; Gottschall S; Randall EL
    J Clin Microbiol; 1987 May; 25(5):787-90. PubMed ID: 3108309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis.
    Smith SM; Eng RH
    Diagn Microbiol Infect Dis; 1988 Apr; 9(4):239-43. PubMed ID: 3141108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
    Traub WH; Geipel U; Leonhard B
    Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
    Aznar J; García Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1984 Feb; 13(2):129-32. PubMed ID: 6423613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of enterococci. I. Inhibitory and bactericidal activity of several chemoantibiotics against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):302-8. PubMed ID: 3098440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
    Sánchez-Silos RM; Pérez-Giraldo C; Blanco MT; Morán FJ; Hurtado C; Gómez-García AC
    Chemotherapy; 2001 Dec; 47(6):415-20. PubMed ID: 11786656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.